18 studies found for:    " March 20, 2007":" April 19, 2007"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Completed PET Evaluation of Brain Peripheral Benzodiazepine Receptors Using [11C]PBR28 in HIV-Seropositive Patients With (MCMD)
Conditions: HIV-Dementia;   HIV-Associated Cognitive Motor Complex;   AIDS Encephalopathy;   AIDS Dementia Complex;   AIDS-Related Dementia Complex;   HIV Infections;   Healthy
Intervention: Drug: [11C]PBR28
2 Completed
Has Results
Treatment Simplification by Darunavir/Ritonavir 800/100 mg Once a Day Versus a Triple Combination Therapy With Darunavir/Ritonavir
Conditions: HIV Infections;   AIDS Virus;   Human Immunodeficiency Virus;   Acquired Immunodeficiency Syndrome Virus
Intervention: Drug: darunavir (DRV, TMC114)
3 Completed Prospective Epidemiological Study Of The Prevalence Of HLA-B*5701
Conditions: HIV Infection;   Infection, Human Immunodeficiency Virus
Intervention: Procedure: Cheek swab & blood test
4 Completed
Has Results
HIV-1 Infection Study of Once a Day Versus Twice a Day Protease Inhibitor in Antiretroviral Treatment Naive Adults
Conditions: Infection, Human Immunodeficiency Virus I;   HIV-1 Infection
Intervention: Drug: fosamprenavir/ritonavir
5 Recruiting Therapeutic Approaches to HAART-Induced Lipodystrophy
Conditions: HIV Infections;   Lipodystrophy
Intervention: Drug: Metreleptin (Leptin)
6 Completed Isoniazid Plus Antiretroviral Therapy to Prevent Tuberculosis in HIV-infected Persons
Conditions: Tuberculosis;   Latent Tuberculosis Infection;   HIV Infections
Interventions: Drug: isoniazid;   Drug: Placebo
7 Active, not recruiting Emtricitabine/Tenofovir Disoproxil Fumarate for HIV Prevention in Men
Condition: HIV Infections
Interventions: Drug: Emtricitabine/tenofovir disoproxil fumarate;   Drug: Placebo
8 Completed Clinical Trial to Assess the Efficacy of Darunavir/Ritonavir (DRV/r), Etravirine (ETV) and Raltegravir (MK-0518) in HIV Patients With Resistant Viruses
Condition: HIV Infections
Interventions: Drug: raltegravir potassium;   Drug: darunavir/ritonavir;   Drug: etravirine;   Drug: Optimized background regimen
9 Completed Mechanisms of Lipodystrophy in HIV-Infected Pateints
Condition: HIV Infections
Intervention: Drug: Viracept versus Sustiva with stavudine and epivir
10 Completed Comparison of Plasma Drug Levels of Triomune 40 With Those of the Originator Products
Condition: HIV Infections
Intervention: Drug: nevirapine, stavudine, lamivudine
11 Completed Subclinical Atherosclerosis in HIV-infected Patients
Conditions: HIV Infections;   Coronary Atherosclerosis
Intervention:
12 Completed Efficacy and Tolerance of the Switch From Enfuvirtine to Raltegravir in Antiretroviral Therapy Regimen in HIV Patients With Undetectable Viral Load
Condition: HIV Infections
Interventions: Drug: FTC/TDF + EFV or LPV/R +T20;   Drug: FTC/TDF + EFV or LPV/R
13 Completed
Has Results
Treatment of Oral Warts in HIV+ Patients
Conditions: Papillomatosis;   HIV Infections
Interventions: Drug: Interferon-alpha;   Other: placebo
14 Completed Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
Conditions: HIV Infections;   Meningitis
Interventions: Biological: Quadrivalent meningococcal conjugate vaccine (MCV4);   Biological: Quadrivalent meningococcal conjugate vaccine (MCV4) booster
15 Completed CMV Disease and IRIS in HIV-1 Infected Persons
Conditions: HIV Infections;   Cytomegalovirus
Intervention: Genetic: IE gene
16 Terminated ESP Study: A Study to Assess the Effect of Adding Fuzeon (Enfuvirtide) to an Antiretroviral Regimen in Fuzeon-Naive Patients With Sustained HIV Viral Suppression.
Condition: HIV Infections
Interventions: Drug: enfuvirtide [Fuzeon];   Drug: Antiretroviral therapy
17 Unknown  Hepatitis Vaccination in HIV Infection: Role of Adjuvant Interleukin-2
Conditions: HIV Infections;   Hepatitis A;   Hepatitis B
Interventions: Biological: Twinrix;   Biological: interleukin-2
18 Completed
Has Results
Enfuvirtide/Current Protease Inhibitor Switch to PREZISTA (Darunavir)/Ritonavir + TMC125 in HIV Patients With Enfuvirtide Side Effects.
Condition: HIV
Intervention: Drug: TMC125, Darunavir; Ritonavir

Indicates status has not been verified in more than two years